COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 657
[17] Fasano A. Intestinal permeability and its regulation by zonulin:
diagnostic and therapeutic implications. Clin Gastroenterol
Hepatol. 2012;10(10):1096-1100.
[18] Vojdani A, Mu Q, Kirby JM, Chen Y, Goebel A. The gut-brain
barrier: role of the intestinal barrier in environmentally triggered
autoimmune brain diseases. Front Immunol. 2022;13:1-23.
[19] Vojdani A, Vojdani E, Saidara E, Kharrazian D. Correlation
between antibodies to bacterial lipopolysaccharides and barrier
protein in sera positive for ASCA and ANCA. World J Gastroenterol.
2017;23(6):1038-1046.
[20] Lord RS, Bralley JA. Clinical applications of urinary organic
acids. Part 2. Dysbiosis markers. Altern Med Rev.
2008;13(4):292-306.
[21] Chu H, Fox M, Zheng X, et al. Small intestinal bacterial
overgrowth in patients with irritable bowel syndrome: clinical
characteristics, psychological factors, and peripheral cytokines.
Gastroenterol Res Pract. 2016;2016:3230859.
[22] Fritscher-Ravens A, Schuppan D, Ellrichmann M, et al.
Confocal endomicroscopy shows food-associated changes in the
intestinal mucosa of patients with irritable bowel syndrome.
Gastroenterology. 2014;147(5):1012-1020.e4.
[23] Morris G, Berk M, Carvalho AF, Caso JR, Sanz Y, Maes M. The
role of microbiota and intestinal permeability in the
pathophysiology of autoimmune and neuroimmune processes
with an emphasis on inflammatory bowel disease type 1 diabetes
and chronic fatigue syndrome. Curr Pharm Des.
2016;22(40):6058-6075.
[24] Leblhuber F, Geisler S, Steiner K, Fuchs D, Schütz B. Elevated
fecal calprotectin in patients with Alzheimer's dementia indicates
leaky gut. J Neural Transm (Vienna). 2015;122(9):1319-1322.
657
